- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Atreca, Gates MRI partner to develop antibody for malaria prevention | ||
| Do | BeiGene's Brukinsa receives approval to treat mantle cell lymphoma in Russia | ||
| Mi | Amgen completes acquisition of biotechnology firm Teneobio | ||
| Mi | Moleculin receives MHRA approval for Phase Ia trial of WP1122 for Covid-19 | ||
| Di | US FDA approves Oyster Point Pharma's nasal spray for dry eye disease | ||
| Di | EMA approves two new sites for making Pfizer-BioNTech's Covid-19 vaccine | ||
| 18.10. | US FDA's VRBPAC recommends J&J Covid-19 vaccine booster shot | ||
| 18.10. | Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics | ||
| 15.10. | Exelixis, STORM partner to develop novel drug leads to treat cancer | ||
| 14.10. | Intellia Therapeutics and SparingVision enter strategic collaboration to develop ocular therapies | ||
| 14.10. | US FDA and EMA accept application for Novartis' Beovu to treat DME | ||
| 13.10. | Poseida, Takeda partner to develop eight in vivo gene therapy programmes | ||
| 12.10. | Pacira BioSciences to buy Flexion Therapeutics | ||
| 11.10. | Brii Biosciences files application for EUA for BRII-196/BRII-198 therapy in US | ||
| 08.10. | Enzolytics, Samsung Biologics partner to develop therapies for HIV, Covid-19 | ||
| 07.10. | AstraZeneca's Alexion concludes Caelum acquisition for $500m | ||
| 06.10. | AstraZeneca seeks FDA EUA for antibody cocktail to prevent Covid-19 | ||
| 05.10. | Australia signs agreement for new Covid-19 drug | ||
| 04.10. | Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia | ||
| 01.10. | Merck signs agreement to buy Acceleron Pharma for $11.5bn | ||
| 01.10. | Trevena reports positive results of TRV027 proof-of-concept trial in Covid-19 patients | ||
| 30.09. | AstraZeneca to acquire remaining stake in Caelum Biosciences | ||
| 30.09. | Appili, AiPharma partner to advance Avigan/Reeqonus global development | ||
| 29.09. | Japanese health ministry approves AstraZeneca's Saphnelo for systemic lupus erythematosus | ||
| 28.09. | Incyte and Syndax to jointly develop and commercialise axatilimab |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
